AGREE 99%.....now let's look at my 1%.....
Let's just
AGREE 99%.....now let's look at my 1%.....
Let's just say that a marketing guy would replace you....probably not a good choice but let's say he started day 1 with your company and well they thought he would work well in that position especially if he was doing it on the cheap....probably be well liked just for that reason......
So company needs to grow so he figured that one of those pay day loans will work cause well it be payed back on payday but the paycheck wasn't as big as planned.....
Then well in the backroom there's this great asset but he needs well money to get machine oiled....well he gets the news that he has to be quiet about it but everybody is so used to him talking all being said still holding a pristine job.....
Now the daunting task of getting others to join him on the cheap working cheap and well not quite sure about Germany but here in America we have bureaucratic hum bo jumbo that well some of us had to live through the Hanging Chad fiasco of an election.....
Other countries have versions of our FDA but not with the hassle.
The machine is something that the world has yet to see working in full force because the BIG companies have people that hang out in lobby's putting money into people's territories.....
So we are at a stage that says we are progressing and anybody that would remember that this world revolves around money and who you know.....
That project could have easily been pushed aside a long time ago and moved on the different route...different project....
If and when we get to realize that this could be for all of humanity then maybe just maybe...
CYDY has had good luck per one of docj posts where they didn't have to get those pay day loans....great product works for many illnesses but well we have American FDA......
I am frustrated too but that does not change anything....pps didn't go up cause I want it too.....FDA didn't move faster cause I said jump.....
Lastly I am trying to figure out why so many people need to see the pps go up and how much would it make 1 person happy cause there'd be someone who says it ain't enough.....
Just ask the millionaire why is he chasing the 2nd and when he reaches that y iz he going for his third.....
I am underwater here but finding a way to stay afloat by having Faith....there is only 1 who knows the number of our days n my luck the day we hit it big I'll probably go by a heart attack and not see it anyways.....now that is my LOL
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
U.S. Takes Stand Against Unfair Import Practices Who knew pizza boxes could stir up such a fuss, huh? Well, here we are. The U.S. International Trade Commission (ITC) has sided with American pizza box manufacturers, waving the flag against those sneaky imports from China, Malaysia, and Turkey. According to the ITC, these imports are causing some real headaches for the...
Continue Reading
Pressure Mounts on Duolingo Amid Legal Turmoil Well, here's a riddle solved with a lawsuit: when an app's growth hits the brakes, the lawyers seem to get moving fast. It seems like Duolingo, Inc. (NasdaqGS: DUOL) is learning a harsh lesson—not exactly in Spanish or French, but in the courtroom. They've been slapped with a securities class action, and it ain't looking...
Continue Reading
AI in Material Science: Beyond Buzzwords There's a lot of talk out there about AI changing the world, but it's always a different tune when it's put under a microscope. At the 2026 Tencent Global Digital Ecosystem Summit, ScienceOra and Wenge AI showcased an AI-assisted workflow for designing hydrogen-production catalysts. This isn't your average AI cheerleading session,...
Continue Reading
Shareholders Fret Over Maplebear's Proposed Transaction It ain't every day a deal's got shareholders fidgeting more than a cat in a dog park, but here we are. Maplebear Inc. (NASDAQ: CART) finds itself under the magnifying glass as the seasoned crew over at Monteverde & Associates PC sound the alarm bells. The firm, sitting cozy in the Empire State Building, is on the...
Continue Reading
Aurora's Rough Road: Production Delays Unveiled You could almost hear the collective groan from investors when Aurora Innovation dropped the bombshell about its truck production delays. You know, after the cheery faces at the Q3 financial results reveal gave way to a rather grim reality check—driverless trucking ain't rolling out quite as planned thanks to those pesky...
Continue Reading
Pledge for Vision In a world where a staggering number of folks wrestle with avoidable vision issues, Orbis International is stepping up to the plate with ambitions that feel as bold as they are necessary. Orbis is pouring a significant $32 million into its mission to beef up eye health systems, train a small army of professionals, and apply AI in eye care. Their big bet...
Continue Reading
Twilio's Legal Troubles: Investors Take Notice Twilio's facing a firestorm, folks. After guiding its organic revenue growth down a few notches, the company saw its shares plummet 17%. Now, they're under the microscope for possibly not playing it straight with their growth numbers, and that’s never a good look with Uncle Sam watching. Folks at Levi & Korsinsky are on the...
Continue Reading
Neuberger Boosts Distribution: What's Driving This? I ain't about to sugarcoat it: the Neuberger Next Generation Connectivity Fund (NYSE: NBXG) decided to jack up its monthly distribution rate to $0.132 per share. This announcement, hitting wallets on November 30, 2026, has a record and ex-date of November 16. Now, that's a good ol' reliable payout for folks holding NBXG...
Continue Reading
Breaking Ground with Bespoke Engineering Fancy seeing a car more unique than a snowflake, eh? Well, Karma Automotive is upending the luxury vehicle market with the launch of the Eximius program. Catering to the whims of the elite who aren’t just satisfied with a plethora of options, this is a game for those who crave a motorized extension of their ego and address book....
Continue Reading
Building Bridges in Healthcare: WesternU's Strategic Move Heck, you know it's the real deal when a university throws a dinner party to celebrate partnerships. Western University of Health Sciences (WesternU) decided to clink glasses with Lebanon community leaders, hammering home the importance of their collaboration on October 6, 2026. Now, don't think this was just some...
Continue Reading
Top 5 Most Recently Viewed Articles
America's Car-Mart Under Investor Scrutiny Recently, America's Car-Mart, Inc. (NASDAQ: CRMT) experienced a noteworthy stock decline as investors reacted to disappointing Q1 2026 financial results. The significant drop of over $8, approximately 18%, raised concerns among shareholders and prompted investigation into the company's operational strategies concerning tariff...
Continue Reading
Lands' End Achieves Significant Financial Milestones DODGEVILLE, Wis. – Lands’ End, Inc. (NASDAQ: LE) has announced its financial results for the fourth quarter and the entire fiscal year 2024, which concluded recently. This announcement follows a year characterized by steady growth and strategic innovation. Strong Performance in the Fourth Quarter During the fourth...
Continue Reading
Wegovy® Demonstrates Hepatic Benefits Beyond Weight Loss Novo Nordisk has recently unveiled intriguing findings regarding Wegovy® (semaglutide 2.4 mg) that highlight its role in enhancing liver health in adults diagnosed with metabolic dysfunction-associated steatohepatitis (MASH), even in the context of limited weight loss. This revelation emerged from a post hoc...
Continue Reading
Measurabl Introduces Free Sustainability Software Measurabl, renowned for its sustainability data platform in real estate, has unveiled a groundbreaking free software solution. This innovative tool allows property and portfolio managers to measure, manage, and report on sustainability performance without any cost. With this recent launch, Measurabl has already registered...
Continue Reading
The Joint Corp. Showcases Remarkable Growth in 2024 Metrics - Adjustments Performed in 2024 Grows 9%, Compared to 2023 - - Receives Letters of Intent for Majority of Corporate Portfolio - SCOTTSDALE, Ariz. — The Joint Corp. (NASDAQ: JYNT), a leader in chiropractic care across the nation, has reported impressive operating metrics for the year ending 2024. The company's...
Continue Reading